Earth Life Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	2016 - 2012
Period Ending	Sep '22 Sep 30, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	2016 - 2012
Net Income	-0.4	-1.58	-1.82	-0.05	-0.44	-6.79	Upgrade
Depreciation & Amortization	-	-	-	0	0	0	Upgrade
Stock-Based Compensation	0.3	1.52	1.79	-	0.4	6.75	Upgrade
Other Operating Activities	0.02	0.02	-	-	-	-	Upgrade
Change in Accounts Payable	0.07	0.03	0.02	0.02	0.04	0.04	Upgrade
Change in Other Net Operating Assets	0	-0	-0.01	-	-	-	Upgrade
Operating Cash Flow	-0	-0.02	-0.02	-0.03	-	-	Upgrade
Short-Term Debt Issued	-	0.02	0.02	0.03	-	-	Upgrade
Total Debt Issued	0	0.02	0.02	0.03	-	-	Upgrade
Short-Term Debt Repaid	-	-	-	-	-0.06	-	Upgrade
Total Debt Repaid	-	-	-	-	-0.06	-	Upgrade
Net Debt Issued (Repaid)	0	0.02	0.02	0.03	-0.06	-	Upgrade
Other Financing Activities	-	-	-	-	0.06	-	Upgrade
Financing Cash Flow	0	0.02	0.02	0.03	-	-	Upgrade
Free Cash Flow	-0	-0.02	-0.02	-0.03	-	-	Upgrade
Levered Free Cash Flow	0.13	-	-	-	-	-	Upgrade
Unlevered Free Cash Flow	0.14	-	-	-	-	-	Upgrade
Change in Working Capital	0.07	0.03	0.01	0.02	0.04	0.04	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.